Limited Liability Partnership registration number OC424993 (England and Wales)
MA PAEDIATRIC ONCOLOGY LLP
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024
MA PAEDIATRIC ONCOLOGY LLP
LIMITED LIABILITY PARTNERSHIP INFORMATION
Designated members
Dr. Maria Michelagnoli
Dr Ananth Shankar
Limited liability partnership number
OC424993
Registered office
c/o Arthur G Mead Ltd
Fitzrovia House
153-157 Cleveland Street
London
W1T 6QW
Accountants
Arthur G Mead Limited
Fourth Floor Fitzrovia House
153-157 Cleveland Street
London
W1T 6QW
MA PAEDIATRIC ONCOLOGY LLP
CONTENTS
Page
Accountants' report
1
Profit and loss account
2
Balance sheet and notes to the financial statements
3
MA PAEDIATRIC ONCOLOGY LLP
ACCOUNTANTS' REPORT TO THE MEMBERS ON THE PREPARATION OF THE UNAUDITED STATUTORY FINANCIAL STATEMENTS OF MA PAEDIATRIC ONCOLOGY LLP FOR THE YEAR ENDED 31 MARCH 2024
- 1 -

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of MA Paediatric Oncology LLP for the year ended 31 March 2024, which comprise the profit and loss account and the balance sheet, from the limited liability partnership’s accounting records and from information and explanations you have given us.

 

As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed at https://www.icaew.com/regulation.

This report is made solely to the limited liability partnership's members of MA Paediatric Oncology LLP, as a body, in accordance with the terms of our engagement letter dated 26 November 2018. Our work has been undertaken solely to prepare for your approval the financial statements of MA Paediatric Oncology LLP and state those matters that we have agreed to state to the limited liability partnership's members of MA Paediatric Oncology LLP, as a body, in this report in accordance with ICAEW Technical Release 07/16 AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than MA Paediatric Oncology LLP and its members as a body, for our work or for this report.

It is your duty to ensure that MA Paediatric Oncology LLP has kept adequate accounting records and to prepare statutory financial statements that comply with the requirements of the Companies Act 2006. You consider that MA Paediatric Oncology LLP is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the financial statements of MA Paediatric Oncology LLP. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.

Arthur G Mead Limited
31 January 2025
Chartered Accountants
Fourth Floor Fitzrovia House
153-157 Cleveland Street
London
W1T 6QW
MA PAEDIATRIC ONCOLOGY LLP
PROFIT AND LOSS ACCOUNT
FOR THE YEAR ENDED 31 MARCH 2024
- 2 -
2024
2023
£
£
Turnover
55,413
57,505
Cost of raw materials and consumables
(46,058)
(49,063)
Other charges
(7,220)
(7,140)
Profit for the financial year before members' remuneration and profit shares
2,135
1,302
MA PAEDIATRIC ONCOLOGY LLP
BALANCE SHEET
AS AT
31 MARCH 2024
31 March 2024
- 3 -
2024
2023
£
£
£
£
Current assets
44,570
44,585
Creditors: amounts falling due within one year
(16,035)
(25,280)
Net current assets
28,535
19,305
Net assets attributable to members
28,535
19,305
Represented by:
Loans and other debts due to members
(50,902)
(57,997)
Members' other interests
79,437
77,302
28,535
19,305
Notes to the financial statements
1
Employees

The average number of persons, excluding members, employed by the partnership during the year was as follows:

2024
2023
Number
Number
Employees
1
1

MA Paediatric Oncology LLP is a Limited Liability Partnership incorporated in England and Wales. The registered office is c/o Arthur G Mead Ltd, Fitzrovia House, 153-157 Cleveland Street, London, W1T 6QW.

For the financial year ended 31 March 2024 the Limited Liability Partnership was entitled to exemption from audit under section 477 of the Companies Act 2006 (as applied by the Limited Liability Partnerships (Accounts and Audit) (Application of Companies Act 2006) Regulations 2008) relating to small limited liability partnerships.

The members acknowledge their responsibilities for complying with the requirements of the Act (as applied to limited liability partnerships) with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the micro-entity provisions and in accordance with FRS 105 'The Financial Reporting Standard applicable to the Micro-entities Regime' and the provisions applicable to LLPs subject to the small LLPs regime.

The financial statements were approved by the members and authorised for issue on 31 January 2025 and are signed on its behalf by:
Dr. Maria Michelagnoli
Dr Ananth Shankar
Designated member
Designated member
Limited Liability Partnership registration number OC424993 (England and Wales)
2024-03-312023-04-01falsefalseCCH SoftwareCCH Accounts Production 2024.301falseOC4249932023-04-012024-03-31OC424993bus:PartnerLLP12023-04-012024-03-31OC424993bus:PartnerLLP22023-04-012024-03-31OC4249932024-03-31OC4249932022-04-012023-03-31OC424993bus:LimitedLiabilityPartnershipLLP2023-04-012024-03-31OC424993bus:Micro-entities2023-04-012024-03-31OC424993bus:AuditExemptWithAccountantsReport2023-04-012024-03-31OC424993bus:FullAccounts2023-04-012024-03-31xbrli:purexbrli:shares